Oxybutynin
Drugs For Urinary Frequency and Incontinence
Sold as VELARIQ
- Drug class
- Drugs For Urinary Frequency and Incontinence
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 4
- Products on record
- 42
Overview
Plain-language summary, compiled from the cited regulatory records
Oxybutynin is a medication classified as a muscarinic antagonist [1]. It is used to treat overactive bladder, addressing symptoms such as urge urinary incontinence, urgency, and urinary frequency [1].
In addition to its use in adults, oxybutynin is also approved for pediatric patients aged 6 years and older who have symptoms of detrusor overactivity linked to a neurological condition, such as spina bifida [1].
Oxybutynin is available under various brand names [1]. In the last 12 months, there have been no adverse event reports submitted [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 32 | May 22, 2026 |
| US United States | FDA | 7 | January 15, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
| EU European Union | EMA | 1 | April 8, 2025 |
GBUnited Kingdom· MHRA
32 products
Uses
1).
How to take
USUnited States· FDA
7 products
Uses
INDICATIONS AND USAGE
, urgency, frequency, urinary leakage, urge incontinence, dysuria).
How to take
CACanada· Health Canada
2 products
Uses
AND CLINICAL USE ..................................................................................................... 3 CONTRAINDICATIONS ......................................................................................................................
4 WARNINGS AND PRECAUTIONS ....................................................................................................... 4 ADVERSE REACTIONS .......................................................................................................................
6 DRUG INTERACTIONS ...................................................................................................................... 9 DOSAGE AND ADMINISTRATION ....................................................................................................
9 OVERDOSAGE ................................................................................................................................. 10 ACTION AND CLINICAL PHARMACOLOGY ..................................................................................
EUEuropean Union· EMA
1 product
Uses
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.
How to take
Drug interactions
Known interactions involving Oxybutynin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 497. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL112430046 · revised May 22, 2026
- [2]FDA DailyMed · 0e002fe8-fa3f-4a… · revised January 15, 2026 [PDF]
- [3]Health Canada (DPD) · 02158590 · revised March 22, 2025
- [4]European Medicines Agency · EMEA/H/C/000532 · revised April 8, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.